The rising prevalence in GLP-1 drugs for diabetes has sparked a debate about delivery methods : patches versus pills . Usually , GLP-1 treatments were only available in pill form, but the emergence of skin applications offers a alternative way. Transdermal systems might benefit individuals experiencing issues taking oral medications, those desiring